Neutropenic fever Flashcards

(43 cards)

1
Q

cause of fever in most neutropenic fever patients

A

endogenous microflora

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

medication associated with reaction of HSV and VZV

A

mTOR inhibitors (sirolimus, everolimus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when ANC is expected to reach nadir with chemo treatment

A

12 to 14 days from day 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cancer type in which neutropenic fever is most common

A

acute leukemia, substantially less common in solid organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

most frequent pathogens in neutropenic fever

A

gram-positive bacteria (anaerobes infrequent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the term for G-CSF and GM-CSF agents?

A

colony stimulating factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is myeloid reconstitution syndrome?

A

Onset or progression of an inflammatory focus defined clinically or radiologically temporally related to neutrophil recovery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

evidence for antibiotic prophylaxis for high risk neutropenic patients?

A

Effective but high NNT, and there are a lot of downsides (cost, side effects, resistance), so should be limited to high risk patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

risk of fungal infection?

A

Very low among patients for whom the anticipated duration of neutropenia (ANC <500 cells/microL) is anticipated to be seven days or fewer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

when risk of neutropenia is highest during chemo

A

typically during the first two cycles of chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

RF’s for neutropenic events

A
  • age >65 years
  • preexisting neutropenia or extensive bone marrow involvement by tumor
  • more advanced cancer
  • poor performance and/or nutritional status - renal or hepatic dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Guideline update on use of colony stimulating factors during COVID-19

A

NCCN and ASCO have lowered the threshold for the use of myeloid growth factors from those chemotherapy regimens which have a 20 percent or higher risk of febrile neutropenia to now include those regimens with a risk of 10 to 20 percent, which includes all of the intermediate-risk chemotherapy regimens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

General term for medications used to

A

Colony stimulating factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why don’t we use CSF’s to treat neutropenic fever?

A

1) Controversial and mixed results. (no effect on mortality, shorter hospital stays in studies, but also increased rates of side effects).
2) It takes several days for CSF to produce a response with increased circulating neutrophils, so antibiotics work faster.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neupogen generic name

A

Filgrastim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

neulasta generic name

A

Pegfilgrastim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

optimal duration of GCSF per guidelines

A

No consensus, guidelines vary
NCCN guidelines suggest daily administration until the post-nadir ANC recovers to normal or near-normal levels by laboratory standards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why neulasta is typically used

A

Multiple RCTs and a meta-analysis have shown that pegfilgrastim is at least as effective as and more convenient to administer than G-CSF for primary prophylaxis in patients requiring CSF treatment during myelosuppressive chemotherapy

19
Q

Potential treatment side effect of CSFs

A

therapy related myeloid neoplasm (a small but real increased risk of therapy-related myeloid neoplasms (myeloid growth factor receptors are expressed by several hematopoietic and nonhematopoietic cell types)

20
Q

Risk of complications in neutropenic fever is based on…

A

duration and severity of neutropenia

21
Q

When do you modify initial antibiotic regimen?

A

IF fever persists after 4 days → add antifungal coverage
Positive infectious workup
Hemodynamic instability
*NOT for persistent with negative workup

22
Q

when people are at increased risk of fungal infections

A
  • prolonged duration of neutropenia (more than 7 days of persistent neutropenia)

- comorbidities

23
Q

how long do you continue abx?

A

Discontinue once myeloid reconstitution (ANC>500) + afebrile x48h

24
Q

Evidence for use of CSF’s in neutropenic fever

A

NOT recommended

25
Median time to deferfescence
- 5 days (in contrast to 2 for solid tumors) | * ***so patients take longer to deferfesce (antibiotic may be covering infection but delay in response)
26
IFI means...
invasive fungal infection
27
Fungitell tests for
b-d-glucan, which is present in a wide variety of fungal pathogens (candida, aspergillus, pneumocystis)
28
Galactomannan tests for
Aspergillus (important cell wall component)
29
Definition of neutropenic fever
- single fever + ANC less than 500
30
outpatient abx for neutropenic fever
Cipro + augmentin
31
Initial therapy for inpatient management of neutropenic fever
Anti-pseudomonal beta-lactam (Cefepime or zosyn)
32
Indications for adding gram-positive coverage
- suspected line sepsis - hemodynamic instability - skin infections
33
ANC cutoff defining neutropenic fever
1000
34
Fever definition
38.3 single oral temp or 100.4 for 1 hr
35
2 most impt variables determining high risk neutropenia
- duration | - comorbidities
36
Decision support tools guiding inpatient vs outpatient management
MASCC (liquid tumor) and CISNE (solid tumor)
37
outpatient abx for neutropenic fever
cipro + augmentin (gram positive coverage)
38
initial abx options
cefepime, zosyn, meropenem
39
IDSA time window for abx for high risk febrile neutropenia
within 1 hr
40
when are people generally speaking at risk for fungal infections?
prolonged neutropenia
41
most common fungus in myeloid malignancy patients with prolonged neutropenia?
aspergillus
42
Mold active azoles
posa, vori, isavuconazole
43
know regimens with 20% or higher risk of febrile neutropenia
``` (think about each cancer subtype) ddMVAC dose dense AC FOLFOXIRI TPF EPOCH Hyper-CVAD Topotecan others (look at NCCN) ```